Product Information
AMITRIPTYLINE HCL 75 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1140 per EA under NDC 16571010801. Its NADAC has been published 147 times since Nov 1, 2023.
FDA first approved this application on May 19, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571010801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217411FDA Approved
5/19/2023
TE Code
AB
On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 75 MG TAB has been published 147 times since Nov 1, 2023, and over the history we have for it it has declined 37.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1140 per EA |
|---|---|
| All-time high | $0.1882 (Apr 10, 2024) |
| All-time low | $0.1009 (Feb 19, 2025) |
| 52-week high | $0.1344 |
| 52-week low | $0.1100 |
| Median price | $0.1191 |
| Average price | $0.1281 |
| Largest weekly change | +47.3% (Mar 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 75 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 75 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1140 per EA (NDC 16571010801), effective Aug 19, 2026.
How has the price of AMITRIPTYLINE HCL 75 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 75 MG TAB has declined 37.7%. It has been tracked across 147 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 75 MG TAB?
Since Nov 1, 2023, the NADAC for AMITRIPTYLINE HCL 75 MG TAB has ranged from a low of $0.1009 (Feb 19, 2025) to a high of $0.1882 (Apr 10, 2024), with a median of $0.1191 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 75 MG TAB?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMITRIPTYLINE HCL 75 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 75 MG TAB?
AMITRIPTYLINE HCL 75 MG TAB (NDC 16571010801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.